申请人:JANSSEN PHARMACEUTICA NV
公开号:US20200155584A1
公开(公告)日:2020-05-21
Disclosed herein are hydroxyethylquercetin glycosides, including compounds of Structural Formulas I, II, III and IV. The compounds disclosed are useful for inhibiting norepinephrine metabolism and treating antenatal and postnatal depression in subjects in need thereof.